surmount-1 trial tirzepatide weight loss nondiabetic and blood pressure reduction: stratified analyses of the randomised controlled SURMOUNT-1 Trial - Cardionerds Twitter

however, we've seen 9 IPOs in the last 14 months, most of which have performed well in the public markets, says Steve Kraus, Partner at Bessemer Venture Partners

Lifestyle Habits That Enhance Natural GLP-1 Signaling Physical activity increases GLP-1 secretion both acutely (during and after exercise) and chronically through improved insulin sensitivity and gut barrier integrity

A biosimilar is a product shown to be highly similar to a reference biologic, and earning that designation requires its own demonstration of comparable pharmacokinetics, pharmacodynamics, and immunogenicity

Hypoglycemia (low blood sugar) is another potential side effect, especially if Ozempic is used in combination with other diabetes medications that lower blood sugar

When GLP-1 agonists slow gastric emptying, large meals sit in the stomach longer, creating that heavy, nauseated feeling